MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing May 26, 2021
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development May 13, 2021
MindMed Inc. Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor Sep 21, 2020
